Webinar: Begin with the End in Mind: Fast-Track Drug Development in Asia
Date: 27 February 2014 | Time: 11am ET / 8am PT | Register Now
Asian markets, particularly Japan, China, and South Korea, offer tremendous growth opportunities for the biopharmaceutical industry. In the past few years changes in the Chinese/Taiwanese, Japanese and South Korean regulatory environments have provided new opportunities for biopharmaceutical companies to incorporate Asian countries' populations into the early stages of their drug development programmes.
Sponsors developing compounds in Europe and North America can employ data from native Asians living in other countries — a concept known as "ethnobridging" — to implement cost-effective, multi-ethnic approaches to their clinical trial programmes.
By incorporating these Asian populations biopharmaceutical companies can accelerate introduction of new products into these important and growing markets. However, for sponsors developing drugs in these countries presents significant challenges including local regulatory guidelines and cultural and ethnic differences.
The key takeaways of this webinar will be:
• How ethnobridging studies can speed up drug development
• Key considerations for conducting ethnobridging studies
• When to incorporate "ethnobridging" studies into the drug development plan
SPEAKERS:
Dr Stan Jhee, Vice President Scientific Affairs, PAREXEL International
Dr Carl Trygstad, Executive Medical and Scientific Advisor, SFJ-Pharmaceuticals
Register Now for continued updates, and access to this live event.
Related News
-
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January. -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi
A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country. -
News CordenPharma joins sustainability initiative to achieve Net Zero
The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. -
News AstraZeneca acquires Neogene in shift into cell-based cancer therapies
AstraZeneca has recently announced that it will be acquiring the biotechnology company Neogene Therapeutics as part of it’s expansion into cell-based cancer treatments.
-
News A mRNA universal flu vaccine is in early stages of development
Researchers from the University of Pennsylvania have developed a universal flu vaccine using nanoparticle encapsulated mRNA. -
News Biovac partnership to increase African vaccine manufacturing capabilities
South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance